BR0201286A - Derivados da 4-amino-piridopirimidina substituìda com biciclos - Google Patents

Derivados da 4-amino-piridopirimidina substituìda com biciclos

Info

Publication number
BR0201286A
BR0201286A BR0201286-3A BR0201286A BR0201286A BR 0201286 A BR0201286 A BR 0201286A BR 0201286 A BR0201286 A BR 0201286A BR 0201286 A BR0201286 A BR 0201286A
Authority
BR
Brazil
Prior art keywords
amino
pyridopyrimidine
bicycles
derivatives
replaced
Prior art date
Application number
BR0201286-3A
Other languages
English (en)
Inventor
Samit Kumar Bhattacharya
John Charles Kath
Joel Morris
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0201286A publication Critical patent/BR0201286A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"DERIVADOS DA 4-AMINO-PIRIDOPIRIMIDINA SUBSTITUìDA COM BICICLOS". A invenção refere-se a piridopirimidinas substituídas na posição 6 ou 7 com um grupo biciclo e na posição 4 com um grupo amino, e aos seus sais, pró-drogas e hidratos farmaceuticamente aceitáveis. A invenção refere-se também às composições farmacêuticas contendo os compostos e aos métodos de tratamento, em um mamífero, de desordens hiperproliferativas de crescimento celular anormal através da administração dos compostos.
BR0201286-3A 2001-04-13 2002-04-12 Derivados da 4-amino-piridopirimidina substituìda com biciclos BR0201286A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28391001P 2001-04-13 2001-04-13

Publications (1)

Publication Number Publication Date
BR0201286A true BR0201286A (pt) 2003-03-11

Family

ID=23088090

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0201286-3A BR0201286A (pt) 2001-04-13 2002-04-12 Derivados da 4-amino-piridopirimidina substituìda com biciclos

Country Status (9)

Country Link
US (1) US6927220B2 (pt)
EP (1) EP1249451B1 (pt)
JP (1) JP4028278B2 (pt)
AT (1) ATE330956T1 (pt)
BR (1) BR0201286A (pt)
CA (1) CA2381513C (pt)
DE (1) DE60212487T2 (pt)
ES (1) ES2263743T3 (pt)
MX (1) MXPA02003796A (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1636195A1 (en) * 2003-05-27 2006-03-22 Pfizer Products Inc. Quinazolines and pyrido[3,4-d]pyrimidines as receptor tyrosine kinase inhibitors
UA96745C2 (en) * 2005-11-22 2011-12-12 Кудос Фармасьютикалз Лимитед PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
JP2010528007A (ja) * 2007-05-23 2010-08-19 メルク・シャープ・エンド・ドーム・コーポレイション シクロプロピルピロリジンオレキシン受容体アンタゴニスト
AU2011328673B2 (en) * 2010-11-09 2016-02-25 Betta Pharmaceuticals Co., Ltd Compound for increasing kinase active and application thereof
CA3175102A1 (en) * 2020-03-13 2021-09-16 Suzhou Zanrong Pharma Ltd. Erbb receptor inhibitors as anti-tumor agents
PE20240327A1 (es) 2021-04-13 2024-02-22 Nuvalent Inc Heterociclos con sustitucion amino para tratar canceres con mutaciones de egfr
WO2022266458A1 (en) * 2021-06-17 2022-12-22 Black Diamond Therapeutics, Inc. 6-heterocycloalkyl-quinazoline derivatives and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884418B1 (en) 1989-08-04 2005-04-26 Berlex Laboratories, Inc. Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy
US6177401B1 (en) * 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
SK72996A3 (en) * 1995-06-07 1997-04-09 Pfizer Heterocyclic ring-fused pyrimidine derivatives and pharmaceutical compositions on their base
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
IL126351A0 (en) 1996-04-12 1999-05-09 Warner Lambert Co Irreversible inhibitors of tyrosine kinases
US6207669B1 (en) 1996-07-13 2001-03-27 Glaxo Wellcome Inc. Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
HRP970371A2 (en) * 1996-07-13 1998-08-31 Kathryn Jane Smith Heterocyclic compounds
EP1028964A1 (en) * 1997-11-11 2000-08-23 Pfizer Products Inc. Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
GB9800575D0 (en) 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
RS49779B (sr) 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
GB2345486A (en) 1999-01-11 2000-07-12 Glaxo Group Ltd Heteroaromatic protein tyrosine kinase inhibitors
JP3270834B2 (ja) * 1999-01-27 2002-04-02 ファイザー・プロダクツ・インク 抗がん剤として有用なヘテロ芳香族二環式誘導体
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
US6297238B1 (en) * 1999-04-06 2001-10-02 Basf Aktiengesellschaft Therapeutic agents
EP1192151B1 (en) 1999-07-09 2007-11-07 Glaxo Group Limited Anilinoquinazolines as protein tyrosine kinase inhibitors
US20050038047A1 (en) * 2003-08-14 2005-02-17 Edwards Paul John Azaquinazoline derivatives

Also Published As

Publication number Publication date
DE60212487D1 (de) 2006-08-03
ES2263743T3 (es) 2006-12-16
CA2381513C (en) 2006-01-10
US20030045535A1 (en) 2003-03-06
DE60212487T2 (de) 2006-12-21
JP2002322178A (ja) 2002-11-08
ATE330956T1 (de) 2006-07-15
JP4028278B2 (ja) 2007-12-26
MXPA02003796A (es) 2002-11-07
EP1249451A2 (en) 2002-10-16
EP1249451A3 (en) 2003-03-12
US6927220B2 (en) 2005-08-09
EP1249451B1 (en) 2006-06-21
CA2381513A1 (en) 2002-10-13

Similar Documents

Publication Publication Date Title
UY28132A1 (es) Derivados de pirrolopirimidina
MY139571A (en) Indolyl derivatives as liver-x-receptor modulators
DOP2001000170A (es) Derivados de tiofeno utiles como agentes anticancesoros
EA200600892A1 (ru) Новые хинолиновые производные
WO2007138472A3 (en) Triazolopyridazine derivatives
ECSP055633A (es) Nuevos derivados de benzoimidazolutiles como angentes antiproliferativos
PT1029853E (pt) Derivados biciclicos heteroaromaticos uteis como agentes anticancerigenos
MXPA06002296A (es) Tienopiridina-fenilacetamidas y sus derivados utiles como nuevos agentes antiangiogenicos.
MY132073A (en) Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
CY1112941T1 (el) Δικυκλικοι αναστολεις της μεκ
EA200100135A1 (ru) Алкинилзамещенные производные хинолин-2-она, полезные в качестве противораковых агентов
YU69902A (sh) Novi derivati piperazina
WO2003000194A3 (en) Thienopyridine and thienopyrimidine anticancer agents
HK1086256A1 (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
NO20055143L (no) Doseringsformer innbefattende AG013736
DE69923849D1 (de) Quinolin-2-on-derivate verwendbar als antikrebsmittel
HK1046374A1 (en) Camptothecin analogs and methods of preparation thereof
BR9805734A (pt) Derivados de imidazolin-4-ona úteis como agentes anticancerìgenos.
WO2003074529A3 (en) iNDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
PT1497289E (pt) Farmaco contendo betamimeticos e um novo anticolinergico
WO2005066167A3 (en) 3-quinuclidinyl heteroatom bridged biaryl derivatives
ES2168581T3 (es) Derivados de indazol sustituidos.
BR0201286A (pt) Derivados da 4-amino-piridopirimidina substituìda com biciclos
WO2006031719A3 (en) 1,4-bis-n-oxide-5,8-dihydroxyanthracenedione compounds and the use thereof

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010.